Efficacy and Safety of Topical Corticosteroids for Management of Oral Chronic Graft versus Host Disease

Article, Review English OPEN
Elsaadany, Basma Abdelaleem ; Ahmed, Eman Magdy ; Aghbary, Sana Maher Hasan (2017)
  • Publisher: Hindawi
  • Journal: International Journal of Dentistry, volume 2,017 (issn: 1687-8728, eissn: 1687-8736)
  • Related identifiers: doi: 10.1155/2017/1908768, pmc: PMC5511636
  • Subject: RK1-715 | Review Article | Dentistry | Article Subject

Background. Oral chronic graft versus host disease (cGVHD) is a major complication in transplantation community, a problem that can be addressed with topical intervention. Topical corticosteroids are the first line of treatment although the choice remains challenging as none of the available treatments is supported by strong clinical evidence. Objective. This systematic review aims to determine the clinical efficacy and safety of topical corticosteroids for the management of the mucosal alterations of oral cGVHD. Data Sources. Electronic search of different databases was conducted: PubMed, Cochrane library, Grey literature, WHO, and clinical trials.gov for clinical trial registration as well as hand search in the references of relevant articles up to November 2016. Data Extraction. Extracted pieces of information were intervention, population, sample sizes, and outcomes. Data Synthesis. Six studies were included: 2 randomized clinical trials (RCTs), 3 cohort studies, and 1 pre-post clinical trial. Results. There is a limited evidence concerning clinical efficacy of topical corticosteroids. Clobetasol, dexamethasone, and budesonide were the topical corticosteroid of choice. The highest level of evidence score was given to clobetasol followed by budesonide with a lower evidence level. Conclusion. All three topical corticosteroid preparations are effective for management of oral chronic GVHD with minimal easily avoided side effects.
  • References (14)
    14 references, page 1 of 2

    Mays, J. W., Fassil, H., Edwards, D. A., Pavletic, S. Z., Bassim, C. W.. Oral chronic graft-versus-host disease: Current pathogenesis, therapy, and research. Oral Diseases. 2013; 19 (4): 327-346

    Schubert, M. M., Correa, M. E. P.. Oral graft-versus-host disease. Dental Clinics of North America. 2008; 52 (1): 79-109

    Imanguli, M. M., Alevizos, I., Brown, R., Pavletic, S. Z., Atkinson, J. C.. Oral graft-versus-host disease. Oral Diseases. 2008; 14 (5): 396-412

    Albuquerque, R., Khan, Z., Poveda, A., Higham, J., Richards, A., Monteiro, L., Jané-Salas, E., Lopez-Lopez, J., Warnakulasuriya, S.. Management of oral graft versus host disease with topical agents: A systematic review. Medicina Oral, Patologia Oral y Cirugia Bucal. 2016; 21 (1): e72-e81

    Higgins, J. P., Green, S.. Cochrane Handbook for Systematic Reviews of [Internet], Version 5.1.0. 2008

    Sign, null. Critical appraisal: Notes and checklists [Internet].

    Noce, C. W., Gomes, A., Shcaira, V., Corrêa, M. E. P., Moreira, M. C. R., Silva Júnior, A., Gonçalves, L. S., Garnica, M., Maiolino, A., Torres, S. R.. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation. 2014; 20 (8): 1163-1168

    Park, A. R., La, H. O., Cho, B. S., Kim, S. J., Lee, B. K., Rhie, J. Y., Gwak, H. S.. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. American Journal of Health-System Pharmacy. 2013; 70 (16): 1383-1391

    Sari, I., Altuntas, F., Kocyigit, I., Sisman, Y., Eser, B., Unal, A., Fen, T., Ferahbas, A., Ozturk, A., Unal, A., Cetin, M.. The effect of budesonide mouthwash on oral chronic graft versus host disease. American Journal of Hematology. 2007; 82 (5): 349-356

    Elad, S., Zeevi, I., Finke, J., Koldehoff, M., Schwerdtfeger, R., Wolff, D., Mohrbacher, R., Levitt, M., Greinwald, R., Shapira, M. Y.. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study. Biology of Blood and Marrow Transplantation. 2012; 18 (1): 134-140

  • Related Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark